Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
Recruiting · NCT05620017 · Registry updated 2026-02-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-02-09 | NCT05620017 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bio-Thera Solutions | 9 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Cancer Hospital of Chongqing University | Chongqing | China | 3 |
| Zhejiang Cancer Hospital | Hangzhou | China | 84 |